Exodus Point Capital Management, LP Nautilus Biotechnology, Inc. Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 19, 2022
SELL
$2.64 - $4.84 $363,860 - $667,077
-137,826 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$3.5 - $5.3 $482,391 - $730,477
137,826 New
137,826 $598,000
Q4 2021

Feb 11, 2022
SELL
$4.45 - $6.21 $59,799 - $83,449
-13,438 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$6.14 - $10.1 $82,509 - $135,723
13,438 New
13,438 $83,000

Others Institutions Holding NAUT

# of Institutions
82
Shares Held
63.9M
Call Options Held
2.9K
Put Options Held
500
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $324M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email